Panacea Journal of Medical Sciences
Official Publication of NKP Salve Institute of Medical Sciences and Research Centre
Official Publication of NKP Salve Institute of Medical Sciences and Research Centre
Print ISSN:-2249-8176
Online ISSN:-2348-7682
CODEN : PJMSD7
Current Issue
Year 2024
Volume: 14 , Issue: 3
Viewed: 194
Emailed: 0
PDF Downloaded: 337
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 14, Issue : 2, Year : 2024
Article Page : 573-578
https://10.18231/j.pjms.2024.103
Abstract
Background: Hemotoxic toxin syndrome, carry a high risk of hemorrhage and death. Snake venom have toxins that cause coagulopathy in a two different mechanism of actions. The snake toxins act as anticoagulant which inhibit clotting cascade or act as procoagulant toxins which activate the clotting cascade and consume clotting factors. The consumption coagulopathy in snake bite is referred to as Venom Induced Consumptive Coagulopathy (VICC). VICC is marked by prolonged clotting time and clotting factor deficiencies and an elevated d-dimer. VICC has a rapid onset and resolves with inactivation of toxins and synthesis of new clotting factors. A subset of VICC develops Thrombotic Microangiopathy (TMA). TMA is different and poorly understood hemotoxic syndrome.
Materials and Methods: We performed a prospective analytical study of all consenting adult patients presenting to Thanjavur medical college, Tamil Nadu with suspected or with clear snake bite history within 24 hours and all Patients with thrombocytopenia less than 1.5 lakh in the first 3 days of hospital stay. All patients with Pre-existing kidney disease with serum creatinine more than 1.4 prior to snake bite and ultrasound evidence of chronic kidney disease were excluded. The study was done from January 2021 to January 2022.
Results: TMA spectrum disorders, including isolated thrombocytopenia, MAHA, and renal failure, are primarily hematological and renal, with severe presentations involving thrombocytopenia, MAH, schistiocytes, and renal failure. Clinicians should monitor tests, administer ASV early, and anticipate further TMA evidence to prevent complications.
Conclusion: Thrombotic microangiopathy should be anticipated in all Hemotoxic snake bite. So early recognition and appropriate management will save the patient lives.
Keywords: Hemotoxic toxin syndrome, Venom induced Consumptive coagulopathy (VICC), Thrombotic microangiopathy, Microangiopathic hemolytic anemia (MAHA)
How to cite : Sundararajan C, Vetrivel S, Abirami S, Charulatha R, A study on thrombotic microangiopathy spectrum disorders in snake bite. Panacea J Med Sci 2024;14(2):573-578
Copyright © 2024 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)
